Skip to main content
Richard Shelton, MD, Psychiatry, Birmingham, AL

RichardCharlesSheltonMD

Psychiatry Birmingham, AL

Charles B. Ireland Professor & Vice Chair for Research, Department of Psychiatry, University of Alabama at Birmingham (UAB)

Dr. Shelton is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Shelton's full profile

Already have an account?

  • Office

    1717 6th Ave S
    Birmingham, AL 35233
    Phone+1 800-822-8816

Education & Training

  • National Institutes of Health Clinical Center
    National Institutes of Health Clinical CenterResidency, Psychiatry, 1983 - 1985
  • Brigham and Women's Hospital/Harvard Medical School
    Brigham and Women's Hospital/Harvard Medical SchoolResidency, Psychiatry, 1980 - 1983
  • University of Louisville School of Medicine
    University of Louisville School of MedicineInternship, Transitional Year, 1979 - 1980
  • University of Louisville School of Medicine
    University of Louisville School of MedicineClass of 1979

Certifications & Licensure

  • AL State Medical License
    AL State Medical License 2012 - 2024
  • TN State Medical License
    TN State Medical License 1985 - 2014
  • American Board of Psychiatry and Neurology Psychiatry

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

Other

Press Mentions

  • 'Conclusive Answer' on Antidepressants in Pregnancy and Kids' Epilepsy Risk
    'Conclusive Answer' on Antidepressants in Pregnancy and Kids' Epilepsy RiskMay 11th, 2022
  • More Seasonal Affective Disorder This Winter? 'It's Obvious This Year Is Different'
    More Seasonal Affective Disorder This Winter? 'It's Obvious This Year Is Different'January 27th, 2021
  • Allergan’s Phase III Botox Trial for Depression Pushed to H2 2019
    Allergan’s Phase III Botox Trial for Depression Pushed to H2 2019December 10th, 2018
  • Join now to see all

Grant Support

  • Neural-Derived Plasma Exosomal MicroRNAs As Promising Novel Biomarkers for Suicidality and Treatment Outcome in AdolescentsNational Institute of Mental Health2022–2027
  • MicroRNA Correlates of Childhood Maltreatment and SuicidalityNational Institute of Mental Health2020–2025
  • MicroRNA Mediators of Early Life Stress Vulnerability and ResilienceNational Institute of Mental Health2017–2020
  • A Double-Blind, Proof-of-Concept (POC) Trial of Low Field Magnetic Stimulation (LFMS) Augmentation of Antidepressant Therapy in Treatment-Resistant Depression (TRD)National Institute of Mental Health/Massachusetts General Hospital (subaward)2011–2016
  • 2/2-Ziprasidone Augmentation Of Ssris For Treatment-Resistant Depression (TRD)National Institute Of Mental Health2008–2011
  • Signal Transduction In DepressionNational Institute Of Mental Health2006–2008
  • Molecular Neurobiology Of DepressionNational Institute Of Mental Health1999–2003
  • Depression--Psychopathology Beyond The ReceptorsNational Institute Of Mental Health1996–2002
  • Comparison Of Mazaperine, Risperidone, And PlaceboNational Center For Research Resources1997
  • Slep Deprivation And Circadian Rhythm In DepressionNational Center For Research Resources1996
  • Rapid Response To Antidepressants In Sleep DeprivationNational Center For Research Resources1994–1996
  • Alprazolam Concentration Response To Lactate Induced Panic AttackNational Center For Research Resources1994–1996
  • Rapid Response To Antidepressants By Sleep DeprivationNational Institute Of Mental Health1990–1994
  • Activity Monitoring In DepressionNational Center For Research Resources1991
  • Pharmacological Investigation Of Neuronal Calcium ChannelsNational Center For Research Resources1987–1989